Application

ENLIGHT-LN REGISTRY

Aurinia Pharmaceuticals Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97253241
Filing Date: 02/04/2022

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97253241
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\972\532\97253241\xml1 \ APP0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT ENLIGHT-LN REGISTRY
COLOR MARK NO
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of The word ENLIGHT-LN in stylized form, bracketed by a design of a radiating light bulb; the word REGISTRY in stylized form is positioned beneath the word ENLIGHT-LN.
PIXEL COUNT ACCEPTABLE NO
PIXEL COUNT 347 x 102
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Aurinia Pharmaceuticals Inc.
*MAILING ADDRESS 1203-4464 Markham St.
*CITY Victoria, B.C.
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Canada
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
V8Z7X8
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE company
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY UNDER WHICH ORGANIZED Canada
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 042 
*IDENTIFICATION Medical research services; medical research and development in the field of lupus nephritis; providing medical and scientific research information in the field of clinical trials; scientific research namely, conducting clinical trials for others in the field of lupus nephritis
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Matthew R. Wilmot
ATTORNEY DOCKET NUMBER 66570-33
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Stoel Rives LLP
STREET 760 SW Ninth Avenue, Suite 3000
CITY Portland
STATE Oregon
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 97205
PHONE 503-294-9851
FAX 503-220-2480
EMAIL ADDRESS TM-PDX@STOEL.COM
OTHER APPOINTED ATTORNEY Anne W. Glazer, Kevin S. Crosman, Randolph C. Foster, Alfredo Villanueva, Elliott J. Williams, Catherine P. Lake, Joshua G. Gigger
CORRESPONDENCE INFORMATION
NAME Matthew R. Wilmot
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE TM-PDX@STOEL.COM
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) patrick.hartigan@stoel.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 350
*TOTAL FEES PAID 350
SIGNATURE INFORMATION
SIGNATURE /Matthew R. Wilmot/
SIGNATORY'S NAME Matthew R. Wilmot
SIGNATORY'S POSITION Attorney of record, Oregon Bar member
SIGNATORY'S PHONE NUMBER 503-294-9851
DATE SIGNED 02/03/2022
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97253241
Filing Date: 02/04/2022

To the Commissioner for Trademarks:

MARK: ENLIGHT-LN REGISTRY (stylized and/or with design, see mark)
The literal element of the mark consists of ENLIGHT-LN REGISTRY. The applicant is not claiming color as a feature of the mark. The mark consists of The word ENLIGHT-LN in stylized form, bracketed by a design of a radiating light bulb; the word REGISTRY in stylized form is positioned beneath the word ENLIGHT-LN.
The applicant, Aurinia Pharmaceuticals Inc., a company organized under the laws of Canada, having an address of
      1203-4464 Markham St.
      Victoria, B.C. V8Z7X8
      Canada
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 042:  Medical research services; medical research and development in the field of lupus nephritis; providing medical and scientific research information in the field of clinical trials; scientific research namely, conducting clinical trials for others in the field of lupus nephritis
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.




The owner's/holder's proposed attorney information: Matthew R. Wilmot. Other appointed attorneys are Anne W. Glazer, Kevin S. Crosman, Randolph C. Foster, Alfredo Villanueva, Elliott J. Williams, Catherine P. Lake, Joshua G. Gigger. Matthew R. Wilmot of Stoel Rives LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      760 SW Ninth Avenue, Suite 3000
      Portland, Oregon 97205
      United States
      503-294-9851(phone)
      503-220-2480(fax)
      TM-PDX@STOEL.COM
The docket/reference number is 66570-33.
Matthew R. Wilmot submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      Matthew R. Wilmot
       PRIMARY EMAIL FOR CORRESPONDENCE: TM-PDX@STOEL.COM
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): patrick.hartigan@stoel.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Matthew R. Wilmot/   Date: 02/03/2022
Signatory's Name: Matthew R. Wilmot
Signatory's Position: Attorney of record, Oregon Bar member
Signatory's Phone Number: 503-294-9851
Signature method: Sent to third party for signature
Payment Sale Number: 97253241
Payment Accounting Date: 02/04/2022

Serial Number: 97253241
Internet Transmission Date: Fri Feb 04 11:01:40 ET 2022
TEAS Stamp: USPTO/BAS-XXX.XX.XXX.XX-2022020411014089
3063-97253241-810fa817485076376413639772
7bdcd5f9da6fad2a89bd698048c45c80c29dc0-C
C-01390971-20220127193440259789

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed